High Prevalence of Non-Vaccinated Oncogenic Human Papillomavirus Genotypes in High-Grade Squamous Intraepithelial Lesions of the Cervix: Thought-Provoking Results of a Detailed HPV Genotype Analysis.
FFPE cone sample
HPV Direct Flow CHIP
HPV genotype profile
HSIL
PAP smear
nonavalent HPV vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
10 May 2022
10 May 2022
Historique:
received:
24
03
2022
revised:
05
05
2022
accepted:
08
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Identification of HPV infection is usually performed on cytological specimens, despite the often transient virus types. HPV profile analysis of pathologically confirmed lesions can also be performed on formalin-fixed paraffin-embedded (FFPE) cone samples and should be taken as standard during follow-up. We compared HPV profiles of cytological and FFPE specimens of women diagnosed with HSIL. Archived PAP smears and FFPE cones from 49 patients were processed. For genotyping, the HPV Direct Flow CHIP test was used. All samples were positive. HPV profile agreement of the two sample types was 84.16-100%. Mono-infections occurred in 12.24% and 61.22% in PAP smears and FFPE specimens, respectively; while multi-infections were detected in 87.76% and 38.78%, respectively. The most abundant genotypes were HPVs 16, 31, and 51/33. Of all infections, 56.25% and 64.93% were caused by nonavalent vaccinated type (VT) HPVs; while 50.69% and 38.96% belonged to non-nonavalent VT HPVs, in PAP smears and FFPE specimens, respectively. Our results confirmed the importance of HPV genotyping of FFPE cone samples. We also confirmed a remarkable presence of non-vaccinated HPV types in HSIL cases indicating the importance of vaccine development.
Identifiants
pubmed: 35632504
pii: vaccines10050748
doi: 10.3390/vaccines10050748
pmc: PMC9146889
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of Pecs
ID : 2020-12
Références
Int J Cancer. 2021 Feb 1;148(3):665-672
pubmed: 32781482
Lancet Infect Dis. 2010 Dec;10(12):862-74
pubmed: 21075056
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1274-80
pubmed: 16835323
Papillomavirus Res. 2019 Dec;8:100179
pubmed: 31377173
Int J Cancer. 2007 Aug 1;121(3):621-32
pubmed: 17405118
Acta Cytol. 2015;59(5):391-8
pubmed: 26674365
Br J Cancer. 2003 Jan 13;88(1):63-73
pubmed: 12556961
J Infect Dis. 2011 Apr 1;203(7):891-3
pubmed: 21402540
Cancers (Basel). 2020 May 05;12(5):
pubmed: 32380733
Cancer Sci. 2016 Oct;107(10):1520-1526
pubmed: 27501394
Virology. 2013 Oct;445(1-2):21-34
pubmed: 23932731
Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2439-45
pubmed: 16214929
Gynecol Oncol. 2014 Jun;133(3):405-8
pubmed: 24657488
Clin Sci (Lond). 2017 Aug 10;131(17):2201-2221
pubmed: 28798073
Ann Oncol. 2020 Feb;31(2):213-227
pubmed: 31959338
Eur J Cancer. 2015 Sep;51(13):1732-41
pubmed: 26121913
Exp Mol Pathol. 2017 Apr;102(2):321-326
pubmed: 28249711
Vaccines (Basel). 2021 Jun 05;9(6):
pubmed: 34198774
APMIS. 2010 May;118(5):346-52
pubmed: 20477809
Cancer Treat Rev. 2006 Nov;32(7):516-23
pubmed: 17008015
J Infect Dis. 2011 Apr 1;203(7):910-20
pubmed: 21402543
J Pathol. 2012 May;227(1):62-71
pubmed: 22127961
Front Oncol. 2019 May 08;9:355
pubmed: 31134154
PLoS One. 2015 Jul 15;10(7):e0132570
pubmed: 26176537
Open Virol J. 2013 Oct 18;7:91-5
pubmed: 24222806
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
J Gen Virol. 1997 Feb;78 ( Pt 2):401-11
pubmed: 9018063
J Clin Virol. 2016 Mar;76 Suppl 1:S88-S97
pubmed: 26514313
PLoS One. 2011;6(7):e21913
pubmed: 21765924
Nucleic Acids Res. 2017 Jan 4;45(D1):D499-D506
pubmed: 28053164
Int J Cancer. 2011 Feb 15;128(4):927-35
pubmed: 20473886
J Low Genit Tract Dis. 2021 Jan 1;25(1):27-37
pubmed: 33105450
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1611-22
pubmed: 18628412
Orv Hetil. 2011 Nov 6;152(45):1804-7
pubmed: 22011366
J Low Genit Tract Dis. 2021 Jul 1;25(3):216-220
pubmed: 34176913
Gynecol Oncol. 2010 May;117(2 Suppl):S5-10
pubmed: 20304221
Cancer Cytopathol. 2017 Feb;125(2):138-143
pubmed: 27870295
J Virol Methods. 2013 Oct;193(1):9-17
pubmed: 23680093
Am J Obstet Gynecol. 2004 Apr;190(4):1046-51
pubmed: 15118639
Nat Commun. 2018 Dec 18;9(1):5360
pubmed: 30560935
Virology. 2009 Feb 20;384(2):260-5
pubmed: 19135222
Br J Cancer. 2003 Jul 7;89(1):101-5
pubmed: 12838308
Int J Cancer. 2010 Feb 1;126(3):684-91
pubmed: 19609952
Clin Vaccine Immunol. 2015 Jul;22(7):679-87
pubmed: 25947147
J Pathol. 2015 Mar;235(4):527-38
pubmed: 25604863
Nat Rev Cancer. 2010 Aug;10(8):550-60
pubmed: 20592731
J Infect Dis. 2021 Aug 2;224(3):481-491
pubmed: 31985011
Vaccines (Basel). 2021 Apr 21;9(5):
pubmed: 33919003